S100A4 in cancer progression and metastasis: A systematic review

被引:146
作者
Fei, Fei [1 ,2 ]
Qu, Jie [1 ,2 ]
Zhang, Mingqing [3 ]
Li, Yuwei [3 ]
Zhang, Shiwu [2 ]
机构
[1] Nankai Univ, Nankai Univ Sch Med, Tianjin 300071, Peoples R China
[2] Tianjin Union Med Ctr, Dept Pathol, Tianjin 300121, Peoples R China
[3] Tianjin Union Med Ctr, Dept Colorectal Surg, Tianjin 300121, Peoples R China
基金
美国国家科学基金会;
关键词
S100A4; metastasis; malignant tumor; epithelial-mesenchymal transition; CALCIUM-BINDING PROTEIN; CELLS IN-VITRO; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN COLORECTAL-CANCER; E-CADHERIN EXPRESSION; PROGNOSTIC-SIGNIFICANCE; MESSENGER-RNA; GENE-EXPRESSION; DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA;
D O I
10.18632/oncotarget.18016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis is the leading cause of cancer-related death and directly associates with cancer progression, resistance to anticancer therapy, and poor patient survival. Current efforts focusing on the underlying molecular mechanisms of cancer metastasis attract a special attention to cancer researchers. The epithelial-mesenchymal transition is a complex of molecular program during embryogenesis, inflammation, tissue fibrosis, and cancer progression and metastasis. S100A4, an important member of S100 family proteins, functions to increase the tumor progression and metastasis. The molecular mechanisms of S100A4 involving in the progression and metastasis are diverse in various malignant tumors. Detection of S100A4 expression becomes a promising candidate biomarker in cancer early diagnosis and prediction of cancer metastasis and therefore, S100A4 may be a therapeutic target. This review summarized up to date advancement on the role of S100A4 in human cancer development, progression, and metastasis and the underlying molecular events and then strategies to target S100A4 expression experimentally.
引用
收藏
页码:73219 / 73239
页数:21
相关论文
共 193 条
[1]   Focal S100A4 protein expression is an independent predictor of development of metastatic disease in cystectomized bladder cancer patients [J].
Agerbaek, Mads ;
Aisner, Jan ;
Marcussen, Niels ;
Lundbeck, Finn ;
Von Der Maase, Hans .
EUROPEAN UROLOGY, 2006, 50 (04) :777-785
[2]   The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor [J].
Ambartsumian, N ;
Klingelhöfer, J ;
Grigorian, M ;
Christensen, C ;
Kriajevska, M ;
Tulchinsky, E ;
Georgiev, G ;
Berezin, V ;
Bock, E ;
Rygaard, J ;
Cao, RH ;
Cao, YH ;
Lukanidin, E .
ONCOGENE, 2001, 20 (34) :4685-4695
[3]  
Ambartsumian NS, 1996, ONCOGENE, V13, P1621
[4]   Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma [J].
Andersen, K ;
Nesland, JM ;
Holm, R ;
Florenes, VA ;
Fodstad, O ;
Mælandsmo, GM .
MODERN PATHOLOGY, 2004, 17 (08) :990-997
[5]   Interferon-γ suppresses S100A4 transcription independently of apoptosis or cell cycle arrest [J].
Andersen, K ;
Smith-Sorensen, B ;
Pedersen, KB ;
Hovig, E ;
Myklebost, O ;
Fodstad, O ;
Mælandsmo, GM .
BRITISH JOURNAL OF CANCER, 2003, 88 (12) :1995-2001
[6]   Update on Survival in Osteosarcoma [J].
Anderson, Megan E. .
ORTHOPEDIC CLINICS OF NORTH AMERICA, 2016, 47 (01) :283-+
[7]  
[Anonymous], ANN SURG
[8]  
[Anonymous], CANCERS BASEL
[9]  
[Anonymous], ELECTRONIC
[10]  
[Anonymous], PROSTATE